ISSN: 0165-5728
Journal Home
Journal Guideline
Journal of Neuroimmunology Q2 Unclaimed
Journal of Neuroimmunology is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 155. It has an SJR impact factor of 0,897 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,897.
Journal of Neuroimmunology focuses its scope in these topics and keywords: multiple, sclerosis, model, icam, antibodies, chronic, brain, polymorphism, progressive, protein, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,897
SJR Impact factor155
H Index156
Total Docs (Last Year)629
Total Docs (3 years)7111
Total Refs1872
Total Cites (3 years)608
Citable Docs (3 years)2.95
Cites/Doc (2 years)45.58
Ref/DocOther journals with similar parameters
Clinical and Experimental Allergy Q2
Expert Review of Clinical Immunology Q2
Immunology and Cell Biology Q2
International Reviews of Immunology Q2
Clinical and Experimental Immunology Q2
Compare this journals
Aims and Scope
Best articles by citations
Pituitary adenylate cyclase-activating polypeptides ( PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP
View moreCytokines and immunity in multiple sclerosis: the dual signal hypothesis
View moreMRI involvement in relapsing remitting MS: Correlation with functional systems and EDSS
View moreIncreased deposition of extracellular matrix components in the thymus gland of MDX mouse: correlation with the muscular lesion
View morePolymorphisms of the promoter region of the tumor necrosis factor a gene and the outcome of MS
View moreAcute unilateral papillitis versus retrobulbar neuritis: Relation to multiple sclerosis
View moreRejection of xenogeneic glial cells grafted into spinal cord white matter results in bystander demyelination
View moreClinical and laboratory evaluation op serum complement and of circulating immune complexes in patients with multiple sclerosis
View moreStatic urethral pressure profile (S.U.P.P.) or video-dynamic pressure profile (V.D.P.P.) in the evaluation of multiple sclerosis (M.S.)?
View moreIntravenous immunoglobulin (IVIG) for the treatment of progressive multiple sclerosis (MS)
View moreThe immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra-and intermolecular dominant epitopes
View moreAntibody dependent cell-mediated cytotoxicity - an additional mechanism in human autoimmune myasthenia gravis
View moreUse of human prolactin as a therapeutic protein to potentiate immunohematopoietic function
View moreMultiple sclerosis associated with familial Mediterranean fever
View moreImpaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis
View moreInterleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor
View moreProlactin in autoimmunity and antitumor defence
View morePreface
View moreLytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study
View moreCTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis
View moreAffective and schizophrenic syndromes as primary symptoms in multiple sclerosis (MS)?
View moreInduction of myelination in the central nervous system by axonal electrical activity
View moreThe effects of recombinant interleukin-1 receptor antagonist (rlL-1ra) on the adoptive transfer of experimental autoimmune encephalomyelitis (EAE) in rats
View moreTGF-beta1-mediated inhibition of glial cell proliferation and down-regulation of ICAM-1 IS interrupted by IFN- gamma
View more
Comments